CJC-1295 (no DAC) Catalog Comparison Notes walks through CJC-1295 (no DAC) (5mg / 10mg) documentation, vial format, and buyer workflow for Growth Research laboratories using sulanpeptide.vip.
CJC-1295 (no DAC), also known as modified GRF (1-29), is a synthetic GHRH analog peptide used in laboratory research on growth-hormone-axis signaling, receptor activation, and short-acting peptide analog behavior without DAC-mediated albumin binding.
Structure–activity studies compare amino-acid substitutions at positions 1–29 for GHRH receptor selectivity versus other class B GPCRs. Perifusion systems measuring GH burst amplitude and frequency are widely cited when evaluating non-DAC GHRH analogs.
Growth-axis research differentiates DAC and non-DAC formats when designing experiments that require discrete GH pulses versus sustained elevation models. Modified GRF(1-29) without DAC preserves shorter half-life suitable for pulse-mimicking perfusion experiments on pituitary cells.
Single-peptide and blend formats serve different experimental designs; confirm protocol needs before selecting CJC-1295 (no DAC). Catalog comparison: Compare CJC-1295 (no DAC) (5mg / 10mg) on vial format, documented purity, and COA access—not product name alone.
Related Growth Research items include CJC-1295 with DAC, CJC1295(no DAC)&IPA, HCG, HGH 191AA. Export spec fields before leadership approval.
Catalog identifiers for CJC-1295 (no DAC): CAS 863288-34-0, Formula: C152H252N44O42. MW 3367.9 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Listed formats for CJC-1295 (no DAC): 5mg10vials, 10mg10vials. Quote emails should include Cat No. (CND5, CND10) so delivered vials match protocol design.
When citing external effect sizes for CJC-1295 (no DAC), match mg strength to published studies.
Price-per-mg comparisons for CJC-1295 (no DAC) should include documentation and shipping—not vial price alone.
CJC-1295 (no DAC) (5mg / 10mg) may compete with single-peptide and blend SKUs in the same research direction. Match protocol design—factorial versus monotherapy—before selecting a catalog line; blends cannot be deconvolved post hoc without separate vials. Literature effect sizes for CJC-1295 (no DAC) experiments often cite specific mg strengths. When comparing suppliers, align delivered specification with published methods—not approximate product names.
Price-per-mg analysis for CJC-1295 (no DAC) should include documentation access, shipping cost, and repeat-order batch continuity—not headline vial price alone. Peer products in Growth Research may differ by receptor target or sequence length even when names sound similar. Mechanism fit review precedes price comparison for CJC-1295 (no DAC).
Catalog comparison for CJC-1295 (no DAC) within Growth Research should export specification fields into a spreadsheet: mg strength, Cat No., purity target, COA availability, and format. Leadership reviews proceed faster with aligned columns than with sequential product tabs.
Peer products in Growth Research may differ by receptor target or sequence length even when names sound similar. Mechanism fit review precedes price comparison for CJC-1295 (no DAC). Catalog comparison for CJC-1295 (no DAC) within Growth Research should export specification fields into a spreadsheet: mg strength, Cat No., purity target, COA availability, and format. Leadership reviews proceed faster with aligned columns than with sequential product tabs.
Price-per-mg analysis for CJC-1295 (no DAC) should include documentation access, shipping cost, and repeat-order batch continuity—not headline vial price alone.
CJC-1295 (no DAC) from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.